M
MDxHealth SA
NASDAQ:MDXH
MDxHealth SA
NASDAQ:MDXH
Price:
3.31
USD
-0.9%
Market Closed
Market Cap:
$163.8m
Relative Value
The Relative Value of one MDXH stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.31 USD, MDxHealth SA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MDXH Relative Value
HIDDEN
Multiples Across Competitors
MDXH Competitors Multiples
MDxHealth SA Competitors
MDxHealth SA Competitors
All Countries
| Market Cap | P/S | P/E | P/B | ||||
|---|---|---|---|---|---|---|---|
| BE |
M
|
MDxHealth SA
NASDAQ:MDXH
|
163.8m USD | 1.1 | -3.2 | -19.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -164 720.7 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.5B USD | 6.6 | 96.2 | -123.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.5B USD | 5.5 | 26.4 | 23.5 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.2B USD | 6.2 | 21.3 | 8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.1B USD | 10.4 | 31.6 | 6.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -5 465.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.9B USD | 5.7 | 18.2 | 2.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.7B AUD | 3.1 | 34.5 | 2.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | 18.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.2B EUR | 11 | 35.2 | 7.5 |
P/S Multiple
P/E Multiple
P/B Multiple
